Lonza Group Ag (OTCMKTS:LZAGY) Sees Significant Growth in Short Interest

Lonza Group Ag (OTCMKTS:LZAGY) was the recipient of a large increase in short interest during the month of January. As of January 15th, there was short interest totaling 27,701 shares, an increase of 393.0% from the December 31st total of 5,619 shares. Based on an average daily volume of 75,219 shares, the short-interest ratio is presently 0.4 days. Currently, 0.0% of the company’s stock are sold short. Currently, 0.0% of the company’s stock are sold short. Based on an average daily volume of 75,219 shares, the short-interest ratio is presently 0.4 days.

Lonza Group Stock Up 2.6%

Shares of LZAGY stock opened at $72.76 on Wednesday. The stock’s fifty day moving average price is $67.97 and its 200 day moving average price is $68.77. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.87 and a current ratio of 1.46. Lonza Group has a 1-year low of $55.57 and a 1-year high of $73.85.

Lonza Group Company Profile

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.